The antitrust trial over Kors’s proposed merger with Coach-owner Tapestry shows how far the handbag maker has fallen.
Related Posts
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.
7-Eleven Parent Asks Circle K Owner to Improve Takeover Bid
Japan’s Seven & i said it would be open to discussions with the Canadian owner of Circle K stores if the latter improves its $39 […]
London-Listed Companies Given More Freedom to Boost Top Executives Wages
The Investment Association simplified its principles of remuneration after a review aimed at ensuring that the U.K. markets continue to attract high-quality companies.